ArticleJugan geon-gang gwa jilbyeong2025
[2023 Tuberculosis Case Notification Status for the Capital Region (Seoul, Incheon, Gyeongggi, Gangwon)].
Article in Jugan geon-gang gwa jilbyeong, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Overview of Tuberculosis Cases Reported in 2024 in the Capital Region: Seoul Metropolitan City, Incheon Metropolitan City, Gyeonggi-do, and Gangwon State.Jugan geon-gang gwa jilbyeong · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This report analyzes tuberculosis (TB) notification trends in 2023 for the Seoul metropolitan area (Seoul, Incheon, Gyeonggi) and Capital region (including Gangwon), aiming to inform regarding effective TB management strategies. Methods: Data from the TB integrated management system (2014-2023) were used to analyze all patients with TB, new patients, older adults (65+ years), foreigners, medical security types, and drug-resistant TB cases. Results: In 2023, the Seoul metropolitan area experienced a 3.6% decrease in the number of patients with TB (8,707 cases), which was less than the national rate. The TB incidence rate among older adults was 107.2/100,000, which was a slight decrease from the incidence rate for the previous year. The incidence among foreigners was 89.9 per 100,000, which was also a decrease. The TB incidence among medical aid recipients (155.0) was 5.3 times higher than that among health insurance subscribers (29.0). Further, the prevalence of multidrug-resistant/rifampicin-resistant tuberculosis (3.1%) was higher than the national prevalence rate (2.8%). Conclusions: The Seoul metropolitan area requires targeted management of older adult, foreign, and medically vulnerable populations. Gangwon requires customized strategies to address aging and access limitations. Different region-specific approaches are needed to reduce the incidence of TB in the Capital region.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.